Savant Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
12,131
+3,092
| +34% | +$119K | ﹤0.01% | 1126 |
|
|
2025
Q1 | $350K | Buy |
9,039
+913
| +11% | +$35.4K | ﹤0.01% | 1133 |
|
|
2024
Q4 | $275K | Buy |
8,126
+2,504
| +45% | +$84.7K | ﹤0.01% | 1150 |
|
|
2024
Q3 | $230K | Buy |
+5,622
| New | +$230K | ﹤0.01% | 1216 |
|
|
2024
Q2 | – | Sell |
-8,871
| Closed | -$380K | – | 1291 |
|
|
2024
Q1 | $380K | Buy |
8,871
+537
| +6% | +$23K | ﹤0.01% | 812 |
|
|
2023
Q4 | $309K | Sell |
8,334
-2,606
| -24% | -$96.6K | ﹤0.01% | 694 |
|
|
2023
Q3 | $397K | Sell |
10,940
-78
| -0.7% | -$2.83K | 0.01% | 580 |
|
|
2023
Q2 | $393K | Buy |
11,018
+1,822
| +20% | +$64.9K | 0.01% | 572 |
|
|
2023
Q1 | $327K | Buy |
9,196
+712
| +8% | +$25.3K | 0.01% | 576 |
|
|
2022
Q4 | $227K | Buy |
+8,484
| New | +$227K | 0.01% | 531 |
|